Literature DB >> 33825803

Reactive Infectious Mucocutaneous Eruption Associated With SARS-CoV-2 Infection.

Zachary E Holcomb1, Sadaf Hussain2, Jennifer T Huang2, Sophia Delano2.   

Abstract

Entities:  

Year:  2021        PMID： 33825803     DOI： 10.1001/jamadermatol.2021.0385

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  5 in total

Review 1.  COVID-19-related oral mucosa lesions among confirmed SARS-CoV-2 patients: a systematic review.

Authors:  Gizem S Erbaş; Aysenur Botsali; Nihan Erden; Canan Arı; Banu Taşkın; Sibel Alper; Secil Vural
Journal:  Int J Dermatol       Date:  2021-09-22       Impact factor: 3.204

Review 2.  Epidemiology and clinical evolution of non-multisystem inflammatory syndrome (MIS-C) dermatological lesions in pediatric patients affected by SARS-CoV-2 infection: A systematic review of the literature.

Authors:  Marcello Lanari; Iria Neri; Arianna Dondi; Giacomo Sperti; Davide Gori; Federica Guaraldi; Marco Montalti; Lorenza Parini; Bianca Maria Piraccini
Journal:  Eur J Pediatr       Date:  2022-08-10       Impact factor: 3.860

3.  Reactive infectious mucocutaneous eruption - repeat etanercept after intravenous immunoglobulin: A case report.

Authors:  Rochelle Tonkin; Malika Ladha; Nicole Johnson; William F Astle; Ami Britton; Neil H Shear; Luis Murguía-Favela; Michele Ramien
Journal:  SAGE Open Med Case Rep       Date:  2022-08-17

4.  Reactive infectious mucocutaneous eruption following COVID-19 in an adolescent boy: Case report and review of the literature.

Authors:  Ayisha Mahama; Priscilla Kojder; Quinn Thibodeaux; Jennifer Ruth
Journal:  Pediatr Dermatol       Date:  2022-08-30       Impact factor: 1.997

5.  Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2.

Authors:  C Yoonhee Ryder; Elisabeth A Pedersen; Jennifer B Mancuso
Journal:  JAAD Case Rep       Date:  2021-10-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.